Serum chitotriosidase activity in gaucher patients on enzyme replacement therapy (ERT)
- 1 July 1998
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 31 (5) , 417-420
- https://doi.org/10.1016/s0009-9120(98)00030-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Plasma chitotriosidase activity in Gaucher disease patients who have been treated either by bone marrow transplantation or by enzyme replacement therapy with algluceraseJournal of Inherited Metabolic Disease, 1997
- Therapeutic delivery of proteins to macrophages: implications for treatment of Gaucher's diseaseThe Lancet, 1996
- Cloning of a cDNA Encoding Chitotriosidase, a Human Chitinase Produced by MacrophagesJournal of Biological Chemistry, 1995
- The Clinical Course of Treated and Untreated Gaucher Disease. A Study of 45 PatientsBlood Cells, Molecules, and Diseases, 1995
- Elevated plasma chitotriosidase activity in various lysosomal storage disordersJournal of Inherited Metabolic Disease, 1995
- Purification and Characterization of Human Chitotriosidase, a Novel Member of the Chitinase Family of ProteinsJournal of Biological Chemistry, 1995
- Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.Journal of Clinical Investigation, 1994
- Binding, internalization, and degradation of mannose-terminated glucocerebrosidase by macrophages.Journal of Clinical Investigation, 1993
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease.Proceedings of the National Academy of Sciences, 1990